Showing 7331-7340 of 23132 results for "".
Kaiser Permanente's Focus on Medical Records
https://reachmd.com/programs/clinicians-roundtable/kaiser-permanentes-focus-on-medical-records/2792/The implementation of the electronic medical record is something many doctors are still thinking about as something on their to-do lists. But there are some medical groups like The Permanente Medical Group of Kaiser Permanente that have been ahead of the curve for years, if not decades. Dr. Robert PIs a Post-Pandemic Recession Headed Our Way?
https://reachmd.com/ma-issues-index/2022-nov-dec/is-a-post-pandemic-recession-headed-our-way/35230/How to prepare your practice to survive a slowdown.Ensitrelvir and Nirmatrelvir: Comparing Viral Clearance in COVID-19
https://reachmd.com/programs/clinicians-roundtable/ensitrelvir-nirmatrelvir--viral-clearance-covid-19/48839/Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations
https://reachmd.com/programs/Audioabstracts/impact-specialized-inpatient-ibd-care-outcomes-ibd-hospitalizations/8408/A look into the implementation of specialized inpatient IBD care for modifying short-term and long-term clinical outcomes for hospitalized patients.Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
https://reachmd.com/programs/neurofrontiers/investigating-inebilizumab-for-generalized-myasthenia-gravis-results-from-mint/35495/Recently published in The New England Journal of Medicine, the phase 3 Myasthenia Gravis Inebilizumab Trial (MINT) underscores the potential of inebilizumab as a therapeutic option for patients with generalized myasthenia gravis (gMG). This is based on the efficacy findings that inebilizumab signifiUpdates in Sleep Medicine for Internists
https://reachmd.com/programs/primary-care-today/updates-in-sleep-medicine-for-internists/6742/Dr. Karl Doghramji speaks on the latest trends and updates from his field of expertise, sleep medicine.Pediatric RSV Hospitalizations Reveal Shifting Risk Profiles Post-Pandemic
https://reachmd.com/programs/clinicians-roundtable/pediatric-rsv-hospitalizations-reveal-shifting-risk-profiles-post-pandemic/37134/Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
https://reachmd.com/programs/project-oncology/tovorafenib-clinical-stability-pediatric-low-grade-glioma/37195/What if clinical stability in pediatric low-grade glioma could be maintained after treatment ends? Emerging data from the phase 2 FIREFLY-1 trial suggest that tovorafenib may offer durable off-therapy disease control, even in the presence of radiographic changes. With a 53% objective response rate,Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
https://reachmd.com/programs/frontlines-schizophrenia/hopeful-recovery-oriented-schizophrenia-diagnosis/49219/The way we deliver a schizophrenia diagnosis can deeply impact a patient’s long-term recovery. That’s why Dr. Alexandria May speaks with Dr. Apurva Bhatt about how we can bring clarity, compassion, and hope to these pivotal conversations. She shares practical strategies for reducing stigma, navigatiHighlighting the Current Status and Future of Theranostics
https://reachmd.com/programs/project-oncology/highlighting-the-current-status-and-future-of-theranostics/24497/What should we know about theranostics? Tune in.